Skip to main content
Clinical Trials/CTRI/2021/06/034142
CTRI/2021/06/034142Not yet recruiting未知

An open-label, randomized, comparative study of the preventive efficacy and safety of Asmidine Spray, metered-dose inhaler versus Salbutamol, metered-dose inhaler, in patients with partially controlled asthma.

VITROBIO SAS0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1 Signed Informed consent form for participation in the clinical study.
  • 2 6.Forced expiratory volume - 1 second (FEV1) before the use of broncholytics not less than 60% of proper value (at screening visit or at the moment of test within 30 days before screening visit).
  • 3 Positive result of the test for reversibility of airway obstruction, expressed as Î?FEV1 >=12% and >=200 ml vs.

Exclusion Criteria

  • 1 Diagnosis of COPD, established according to the GOLD guidelines, ver. 2018.
  • 2 6.Conditions requiring the use of systemic GCS at the time of the screening visit.
  • 3.Unexpected and progressive deterioration of control of symptoms of BA.
  • 4.Unstable course of bronchial asthma, hospitalization due to exacerbation of bronchial asthma in the intensive care unit using intubation, frequent exacerbations of asthma
  • 5.Pulmonary tuberculosis (active or inactive form).
  • 6. covid positve

Investigators

Similar Trials